golimumab
janssen,merck
['axspa']
 abs 0545 cont'd
1* outcome: % without flare continued gol was superior to withdrawal more data on biologic withdrawal in axspa #acr22
@bu_bmc_rheum | @rheum_covid @spartan_updates @official_asas | @UWRheum @UWEpidemiology 2020 | @OHSUIMres 2017 | @UTMBhealth 2014 | @UTAustin 2010